2 results match your criteria: "Groupe hospitalier Cochin-Saint Vincent de Paul and University Paris Descartes[Affiliation]"
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
J Clin Endocrinol Metab
March 2019
Dutch Growth Research Foundation, Rotterdam, Netherlands.
Context: There has been concern that GH treatment of children might increase meningioma risk. Results of published studies have been inconsistent and limited.
Objective: To examine meningioma risks in relation to GH treatment.
Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003.
Arch Pediatr Adolesc Med
February 2012
Department of Biostatistics, Groupe hospitalier Cochin-Saint Vincent de Paul and University Paris Descartes, France.
Objective: To assess the efficiency of the French national screening program for 21-hydroxylase deficiency (21-OHD). Neonatal screening for congenital adrenal hyperplasia due to 21-OHD is mainly intended to prevent death due to salt wasting but remains controversial because of the number of false-positive results and the ease with which most female cases can be identified by virilized genitalia at birth.
Design: Population-based study.